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Summary 
Macrophage-derived nitric oxide (NO) is cytostatic to tumor cells and microbial pathogens. We 
tested whether one molecular target for the cytostatic action of NO may be ribonucleotide reductase 
(RR),  a rate-limiting enzyme in DNA synthesis.  In a concentration-dependent manner, NO 
gas and lysates of activated macrophages that generated comparable amounts of NO led to the 
same degree of inhibition of partially purified RR from L1210 mouse lymphoma cells. Lysates 
from nonactivated macrophages, which do not produce NO, were noninhibitory. With lysates 
from activated macrophages, RR was protected by omitting t-arginine or by adding the NO 
synthase  inhibitors  diphenyleneiodonium,  N'~-methyl+arginine,  or  N'~-amino+arginine. 
t-Arginine, but not D-arginine,  abolished the protective effect of N'~  The 
prototypic pharmacologic inhibitor of IkR is hydroxyurea. Its structural resemblance  to N '~- 
hydroxy-t-arginine, a reaction intermediate of NO synthase, prompted us to test if hydroxyurea 
can generate NO. In the presence of H202 and CuSO4, hydroxyurea produced NO2-/NO3-, 
aerobic  reaction products of NO.  Addition of morpholine blocked NO2-/NO3-  generation 
from hydroxyurea and led to formation of nitrosomorpholine, as detected by gas chromato- 
graphy/mass spectrometry. Thus, hydroxyurea can produce an NO-like,  nitrosating reactant. 
L1210 cell DNA synthesis was inhibited completely by activated macrophages or by hydroxyurea, 
and was partially restored to the same degree in both settings by providing deoxyribonucleosides 
to bypass the block in RR. Thus, both NO gas and NO generated by activated  macrophage 
lysates inhibit tumor cell RR.  The RR inhibitor hydroxyurea can also generate an NO-like 
species. Similar, partial restoration of tumor cell DNA synthesis by deoxyribonucleosides in the 
presence of activated macrophages or hydroxyurea suggests that cytostasis by activated macrophages 
and by hydroxyurea has comparable mechanisms, including, but probably not limited to, inhibition 
of RR. 
A 
tivated macrophages can generate large amounts of ni- 
tric oxide (NO) t from L-arginine (1-8).  NO mediates 
many of the cytotoxic actions of macrophages toward tumor 
cells (2, 6, 8) and microbial pathogens (reviewed in reference 
9). Inhibition of tumor cell respiration by activated macro- 
phages (10, 11) and by NO (6, 8) is biochemically  comparable. 
Before their mitochondria are damaged, however, tumor cells 
incubated with activated macrophages stop synthesizing DNA 
(2, 8, 12). This early cytostatic effect is also mediated by NO 
(6,  8),  but its mechanism is unknown. 
Authentic NO can react with iron (13), iron-sulfur centers 
(7),  and thiols (14). NO-producing macrophages generate 
endogenous iron-nitrosyl complexes (15, 16), and inhibit iron- 
sulfur enzymes in tumor cells with which they are cultured 
(2, 6, 8, 11). Ribonucleotide reductase (RR), a rate-limiting 
1  Abbreviations  used in this paper: FAD, flavin  adenine  dinucleotide;  GC/MS, 
gas chromotography/mass  spectrometry;  re~z, mass-  to -charge  ratio; NO, 
nitric oxide; RR, ribonucleotide  reductase. 
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enzyme in DNA synthesis,  depends on thiols (17, 18) and 
on non-heine iron in its reaction center (17, 19), which are 
crucial for maintaining a key tyrosyl radical (20). Thus, RR 
is a candidate for inactivation by NO, and inactivation of RR 
might explain the cytostatic effect of NO-producing macro- 
phages (8,  12). 
In this report, we demonstrate that NO from activated 
macrophages can inactivate RR from tumor cells. We have 
assessed what proportion of tumor cell cytostasis could be 
ascribed to inhibition of RR, and compared the results  to 
those obtained with NO gas  and with the RR inhibitor 
hydroxyurea. Unexpectedly, hydroxyurea also proved capable 
of generating an NO-like species. 
Materials and Methods 
Materials.  L1210  mouse  lymphoma  and RAW 264.7 mouse  mac- 
rophage cell lines were from the American Type Culture Collec- 
tion (Rockville,  MD). RPMI 1640, MEM (cz-modification),  peni- 
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media), thymidine, 2'-deaxyadenosine, and 2'-deoxyguanosine were 
from JRH Biosciences.  (Lenexa, KS) NADPH, L-arginine, D-ar- 
ginine, Mn-superoxide dismutase (from Escherichia coli), hydrox- 
yurea, snake venom (from Crotalus atrox), ferredoxin (from Clos- 
tridiura pasteurianum), sodium borate, LPS (from E. coli 0128:B12), 
FAD,  magnesium  acetate,  Trizma  base,  dithioerythritol,  5'- 
adenylylimidodiphosphate, dCMP, CDP, cytidine, and deoxycyti- 
dine (for the RR assay) were from Sigma Chemical Co. (St. Louis, 
MO). Catalase (bovine liver) was from Calbiochem-Behring Corp. 
(La Jolla, CA). Dowex 1-X8 (200-400 mesh) was from Bio-Rad 
Laboratories  (Richmond, CA). (6iL,  S)-erythro-5,6,7,8-tetrahydro- 
biopterin was from Dr. 13. Schircks (Jona, Switzerland). [Methyl- 
3a]thymidine, [U-14C]CDP, and [5-3H]CDP were from New En- 
gland Nuclear  (Boston,  MA).  NO  gas  and Nz gas  were from 
Matheson Gas Products (East Rutherford, NJ). N~-Methyl-t-ar  - 
ginine, N~-amino-t-arginine, and diphenyleneiodonium were gifts 
of Dr. Owen W. Griftth (Cornell University Medical College). 
Pure, recombinant mouse IFN-~/was a gift of Genentech (South 
San Francisco,  CA). 
RR Preparations.  RR. was partially purified from L1210 cells 
grown in humidified 5% COs, 95% air at 37~  in 3-liter spinner 
bottles containing RPM11640 supplemented with bovine calf serum 
(10%), penicillin  (50 U/ml), streptomycin (50/~g/ml), and L-glu- 
tamine (2 mM). When the cells reached a density of 0.5-0.7  x 
l@/ml,  they were collected by centrifugation at  4~  and re- 
suspended in 0.9% NaC1, 25 mM glucose. Cell number was deter- 
mined by a nuclear counting method (21) and viability by trypan 
blue exclusion. The cells were then pelleted and lysed by three cycles 
of freezing and thawing in cold distilled water containing protease 
inhibitors (0.1 mM PMSF, 5/zg/ml aprotinin,  1/~g/ml chymostatin, 
5/~g/ml pepstatin A). Cell viability was >90% before and <5% 
after lysis. Lysate from 3-4  x  109 cells was centrifuged at 100,000 
g for 2 h at 4~  Solid ammonium sulfate (0.243 g/liter) was added 
with stirring at 4~  to the supernatant over 30 rain (22). The so- 
lution was further stirred for 30 min and centrifuged at 22,000 
g for 30 min. The precipitate was dissolved with 4 ml of 50 mM 
Tris-HC1, pH 7.6, dialyzed against 1 liter of 2.5 mM sodium phos- 
phate, pH 7.5, for 15 h, and stored at  -80~ 
Macrophage NO Synthase Preparations.  The cytosolic fraction of 
RAW 264.7 ceils was used as the source of NO synthase.  Macro- 
phages were cultured, harvested, and lysed as described previously 
(23).  The ceils were incubated for 12 h with (activated cells) or 
without (control cells) IFNw and LPS before harvest. 
Protein Assay.  The protein concentration of ILK and NO syn- 
thase preparations was measured by the Bradford method (24) using 
Bio-Rad Laboratories protein assay solution with BSA as a standard. 
Treatment of RR with Authentic NO or NO Synthase.  N2 was 
bubbled for 30 min through Tris-HC1 buffer (10 mM, pH 8.0) in 
a test tube closed with a serum stopper to remove dissolved ox- 
ygen. Authentic NO gas was passed through 1 N KOH, and then 
bubbled into the deoxygenated buffer for 10 s. During this time, 
the head space of the test tube was ventilated with N2. The ini- 
tial concentration of NO was measured by exposing an aliquot of 
the NO solution to air, then measuring nitrite plus nitrate as de- 
scribed below. Another aliquot of NO solution was transferred to 
an ILK preparation (5 mg protein/ml 10 mM Tris-HC1,  pH 8.0) 
equilibrated with air. The mixture was incubated for 15 rain at 
25~  and its ILIL activity measured as described below. Alterna- 
tively, partially purified ILR (5 mg protein/ml) from L1210 was 
preincubated with macrophage lysate (4 mg protein/ml) in the pres- 
ence of Mn-superoxide dismutase (200 U/ml), catalase (1,000 U/ml), 
1 mM L-arginine, 0.25 mM NADPH, 4/~M 5,6,7,8-tetrahydro- 
biopterin (25),  and 4/~M FAD (26) for 45 min in 10 mM Tris- 
HCI, pH 8.0, at 37~  For assay of NO synthase activity under 
the same conditions, duplicate samples were prepared for the co- 
incubation of macrophage lysate with L1210 cell ILK as described 
above, except that radiolabeled  CDP was omitted. Nitrite plus ni- 
trate were measured as indicated below. 
Assay of  RR Activity.  After the preincubation described above, 
RR activity was assayed by the conversion of radioactive CDP to 
dCDP, measured as described, with minor modifications (27-29). 
The reaction mixture was incubated with 47/~M FeC13, 3.8 mM 
magnesium  acetate,  5.6  mM  dithioerythritol,  1.9  mM  5'- 
adenylylimidodiphosphate,  and 20 mM sodium phosphate, pH 6.5, 
for 30 min at 37~  in the presence of 25/zM radioactive substrate 
CDP, either [U-14C]CDP (sp act, 6.5 mCi/mmol) or [5-3H]CDP 
(131 mCi/mmol). At the end of the assay incubation, the reaction 
mixture (160/~1) was boiled for 3 rain, then treated with snake 
venom for 2 h at 37~  to convert nucleorides to nucleosides (30). 
The treatment was performed by adding 50/~1 snake venom (40 
mg/ml) and 50/~1 dCMP-magnesium acetate solution (5 mM dCMP 
and 20 mM magnesium acetate in 100 mM Tris-HC1,  pH 9.0). 
The snake venom-treated sample was boiled again for 3 min. Cold 
cytidine and deoxycytidine (8/~g each) were added.  The mixture 
was centrifuged at 10,000 g for 15 min. Radioactive deoxycytidine 
(derived from dCDP, the product of the RR-catalyzed reaction) 
in the supernatant was separated  from cytidine (from CDP,  the 
substrate)  by chromatography  on  columns  containing  Dowex 
1-borate.  Dowex 1-borate was prepared as described with minor 
modifications (28). Dowex 1-X8 was washed with water four to 
five times to remove fines and then washed with saturated sodium 
borate. The resin (1 ml) was packed into a disposable plastic column 
(10-ml capacity; Bio-Rad Laboratories)just before use. The column 
was washed with 4 ml saturated sodium borate and then with 7 
ml water before addition of the sample. Deoxycytidine was eluted 
with 6 ml water and radioactivity of the eluate measured. 1 U  of 
ILK activity was defined as I nmol of CDP converted from dCDP 
during the 30-min incubation under the conditions described above. 
The assay is based on the selective retention of c/s-diols by Dowex- 
borate and hence should not be affected by the possible conversion 
of dCyt into dUrd by contaminating deaminases. 
Assay of Nitrogen Oxides.  Nitrite plus nitrate,  the accumulating 
oxidation products of NO, were measured by the colorimetric Griess 
reaction after reducing nitrate  to nitrite on  a copper-cadmium 
column, as described (31). 
Generation of Nitrogen Oxides  from Hydroxyurea.  Hydroxyurea 
(0.3 or 1 mM) was mixed with CuSO4 (1-20/zM). Sodium phos- 
phate (2.5 mM, pH 7.5) and HzOz (1-2 mM) were added to start 
the reaction. After 60 min at 37~  the reaction was stopped by 
addition of catalase (1,000 U/ml) and EDTA (0.1 mM), and the 
concentration of nitrite, or nitrite plus nitrate, was measured. 
Gas Chromatography/Mass Spectrometry (GC/MS).  The Cu(II)/ 
H~O2 (10 /~M/2  mM)-mediated oxidation of hydroxyurea (0.3 
raM) was performed in 100 mM Tris-HC1, pH 8.0, in the presence 
of 10 mM morpholine to trap NO (32). 5 ml of the reaction mix- 
ture was mixed with dichloroethane (2.5 ml) to extract nitrosomor- 
pholine. The lower layer containing dichloroethane was concen- 
trated to 50/~1 under N2 at 25~  Analysis of nitrosomorpholine 
in the concentrated sample (2/~1) was performed using a 5890 gas 
chromatograph and a 5970 mass selective detector (Hewlett-Packard, 
Avondale, PA). An HP-1 dimethylpolysiloxane column (length, 12 
m; inner diameter,  2  x  10 -4 m, film thickness,  3  x  10 -7 m) was 
used for the gas chromatography. The column temperature was 
initially 60~  and then increased to 140~  at a rate of 20~ 
after 2 min. The carrier gas was helium at a flow rate of 1.05 ml/min 
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transfer line temperature was 225~  Electron impact ionization 
was achieved at 70 eV and an ion source temperature was 220~ 
Abundances of fragmented ions between m/z 50 and rn/z 140 were 
analyzed by an attached computer. 
Effects of Exogenous DeoxFibonucleosides on the Cytostatic Activity 
of  Macrophages or Hydroxyurea.  Thioglycollate broth-elicited peri- 
toneal macroFhages were obtained from CD1 female mice and ac- 
tivated in vitro with IFN-y (2.5-50 U/ml) and LPS (0.5/~g/ml) 
in 96-weU  plates (1.5  x  llY ceUs/we11) as described (8).  MEM, 
s-modification, with bovine calf serum (8%), penicillin (50 U/m1), 
streptomycin (50/zg/ml), and t-glutamine (2 raM) was used. The 
medium (100/~1) was changed twice after a 12-h incubation in 5% 
CO2 at 37~  L1210 cells (70 #1, 0.5  x  10  s ceils/well) were then 
added.  10/~I [methyl-3H]thymidine (0.5/xCi/well,  sp act 2 Ci/ 
retool) was added after a 1-h incubation. After 0.5 h, 0.4 mM deox- 
yadenosine and 0.4 rnM deoxyguanosine (in 20/zl) were added for 
a further 3.5 h.  Nitrite was measured in 50/xl of the medium, 
and thymidine incorporation was measured in the rest of the cul- 
ture using a PHD cell harvester (Cambridge Technology Inc, Water- 
town,  MA). 
Results 
Inactivation of RR by NO Gas.  In a concentration-depen- 
dent manner, NO gas inhibited RR partially purified from 
L1210 lymphoma cells (Fig.  1). Addition of 0.23 mM NO 
reduced RR activity by 37% within 15 min at 25~  (Fig. 
1). As a control, the buffer in which NO was dissolved was 
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Figure 2.  Inactivation of RK by NO synthase in lysates of activated 
macrophages. Partially purified RR (5 mg protein/ml) was incubated with 
NO synthase from activated macrophages (4 nag protein/ml) in the pres- 
ence of Mn-superoxide dismutase (200 U/ml), catalase (1,000 U/ml), 0.25 
mM NADPH, 4/~M tetrahydrobiopterin, and 4/~M FAD. t-Arginine (1 
raM), diphenyleneiodonium (DPI, 10/~M),/~-methylq.-argirfine  (NMA, 
0.5  raM),  N~-amino-t-arginine  (NAA,  0.5  raM),  and  excess L- or 
D-arginine (10 mM) were further added as indicated. After incubation for 
45 min at 370C, RR activity was measured. Cross-hatched bars indicate 
RR activities; solid bars indicate the concentration of nitrite plus nitrate 
generated. Bars and brackets indicate the mean and SD of triplicates. 
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Figure 1.  Inactivation of RK activity by authentic NO. NO gas was 
dissolved in deoxygenated 10 mM Tris-HC1, pH 8.0. Varying volumes 
of the NO solution (0) were added to an aerated preparation of RR for 
15 rain at 25~  after which RR activity was measured under aerobic 
conditions over an additional 30 min. As a control (O), aliquots of NO 
solution were aerated to oxidize NO before its addition to the RR prepa- 
ration. 1 U of KK was defined as the activity converting 1 nmol of CDP 
to dCDP during  the 30-min assay. NO was measured as described in 
Materials and Methods. Data are means _+ SD for triplicates. Where error 
bars are not visible, they are smaller than the symbol representing the mean. 
aerated  before its  addition to  the RR  preparation.  This 
markedly diminished its inhibitory effect, consistent with the 
rapid oxidation of NO to nitrite/nitrate in oxygenated, aqueous 
media (8). Incomplete inhibition of RP.. may likewise have 
resulted from rapid oxidation of NO by Oz in the RR prep- 
aration during the co-incubation, and/or from reaction of 
NO with the iron and thiol needed to demonstrate RR ac- 
tivity. 
Inactivation of RR by NO Generated by Lysates of Activated 
Macrophages.  Partially purified L1210 cell RK was incubated 
with the NO-generating cytosohc fraction of activated RAW 
264.7 murine macrophages in the presence of NADPH, tetra- 
hydrobiopterin,  and FAD. RR  activity was not detected in 
the macrophage cytosol itself at the concentration used. Upon 
addition of 1 mM t-arginine to the co-incubate, RR activity 
was reduced  36%  (Fig.  2),  coincident  with  the accumula- 
tion of 0.14 mM nitrite/nitrate.  Incubation beyond 45 min 
led to an increase in nitrite/nitrate  production,  but did not 
cause additional  inactivation  of RR  (not' shown).  RR  ac- 
tivity was protected when NO generation was inhibited by 
agents from both of the known classes of inhibitors of mac- 
rophage NO synthase: diphenyleneiodonium,  an irreversible 
inhibitor  that appears to interact with NO  synthase via its 
flavin- and/or NADPH-binding  sites (33), and the competi- 
tive  substrate  analog  inhibitors  N~-methyl-r.-arginine  and 
N'~-amino-t-arginine  (34).  The  protective  effect  of  N ~- 
amino-L-arginine was abolished by excess t-arginine, but not 
by o-arginine.  Under  all these conditions,  there was an in- 
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The RR preparation (0.5 mg protein) was preincubated with different 
amounts of lysates from activated macrophages (main figure)  or nonacti- 
voted macrophages (inset) in the presence  of Mn-superoxide dismutase, cata- 
lose, L-arginine, NADPH, tetrahydrobiopterin,  and FAD at 37~  The 
reaction volume was 100 #1. After the incubation, R.R activity (e, O) 
and production of nitrite plus nitrate (&) were measured. Data are means 
_+  SD of triplicates. 
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Figure 4.  Oxidation of hydroxyurea to nitrite/nitrate. Hydroxyurea (1 
mM) was incubated with varying concentrations of CuSO4 (O, no addi- 
tion; e,  1/zM; ~7, 5 #M; V, 10 #M; [~, 20/zM) in the presence of 
1 mM H202 in 2.5 mM sodium phosphate, pH 7.5, at 37~  After the 
indicated periods of incubation, samples  were analyzed  for nitrite plus nitrate. 
verse correlation between NO production (reflected in the 
accumulation of nitrite/nitrate) and ILK activity (Fig. 2). 
Dependence of Inhibition of RR on Amount of Macrophage 
Cytosol, and on Macrophage Activation.  When ILK was ex- 
posed to increasing amounts of activated macrophage cytosol, 
NO generation increased and RR activity diminished in par- 
allel (Fig. 3). Accumulation of as little as 35 #M nitrite/ni- 
trate was associated with a 38% reduction in RIL activity. 
Additional production of NO was associated with progres- 
sively less inhibition of ILIL. When macrophages  had not 
been exposed to IFN-3' and LPS, their lysates were unable 
to produce NO or to inhibit RR over the entire range of 
amounts of lysate tested (Fig. 3, inset). 
Oxidation of Hydroxyurea to Nitrite~Nitrate.  Hydroxyurea 
resembles the N-hydroxyguanidine group of N~~  - 
arginine, an intermediate in NO production by macrophage 
NO synthase (35). This prompted us to consider that hydrox- 
yurea might generate NO within cells. As a model for pos- 
sible oxidative metabolism of  hydroxyurea, we exposed hydrox- 
yurea (1 raM) to H202 (1 raM) in the presence of CuSO4 
(1-20/zM). This led to a time-dependent accumulation  of 
nitrite/nitrate (Fig. 4). Nitrite/nitrate generation was optimal 
at 5/zM Cu(II), but was not supported by Fe(II) nor Fe(III). 
No nitrogen oxides were detected if H202 was omitted, or 
if catalase (500 U/ml) or EDTA (1 raM) were added (data 
not shown). 
Inhibition of Nitrogen Oxide Generation  from Hydroxyurea by 
Ferredoxin and Morpholine.  Oxidation of hydroxyurea might 
form nitrate/nitrate directly, or could generate a more reac- 
tive oxide of nitrogen as an immediate product. To help dis- 
tinguish between these possibilities, we added ferredoxin from 
Clostridium pasteurianum (7) or morpholine (32), which are 
both known to react with NO or certain of its oxidation 
products  (such  as N203  or  N204;  reference 36),  but not 
with nitrite or nitrate under the same conditions. In the con- 
trol, 58/zM nitrite was produced after 1 h from the oxida- 
tion of 300 #M hydroxyurea with I mM H202 and 10 #M 
CuSO4. Ferredoxin (0.1 mg/ml) inhibited nitrite production 
by 76%. Inhibition was not overcome by increasing the con- 
centration of Cu(II) (Fig. 5 A). As a control, albumin was 
tested in place of ferredoxin. Albumin was also inhibitory, 
but in this case, inhibition was readily reversed by increasing 
the concentration of Cu(II) (Fig. 5 B), suggesting that al- 
bumin acted as a chelator of Cu(II). Like ferredoxin,  mor- 
pholine  effectively blocked  nitrite/nitrate generation from 
hydroxyurea, with an ICs0 of 40/~M (data not shown). 
Detection of Nitrosomorpholine by GC/MS.  When the ox- 
idation of hydroxyurea (0.3 raM) with Cu(II) (10 #M) and 
H202 (2 mM) was carried out, 0.1 mM nitrite accumulated. 
However, in the presence of 10 mM morpholine, nitrite could 
no longer be detected. GC/MS analysis of this reaction mix- 
ture contained a product eluting at 3.8 rain that displayed 
a molecular ion of m/z 116 and a base fragment ion of m/z 
56 (Fig. 6). The mass spectrum was identical with that of 
nitrosomorpholine generated by reaction with NO gas. Nei- 
ther nitrite nor nitrate (0.1 mM) led to the formation of 
nitrosomorpholine from morpholine in the presence of the 
Cu(II)/H202. 
Effects of Exogenous Deoxyribonucleosides on the Cytostatic 
Effects of Intact, Activated Macrophages and Hydroxyurea.  Ex- 
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Figure 5.  Inhibition  of nitrite production from hydrox- 
yurea by ferredoxin but not by albumin. The ability of 
CuSO4 at the indicated concentrations and H202 (1 mM) 
to generate nitrogen oxides from hydroxyurea (0.3 mM) 
was examined without further  additions (O) or in the 
presence of Clostridium pasteurianum ferredoxin (A) or BSA 
(B) at concentrations of 0.1 mg/ml (V), 0.01 mg/ml (~), 
or 0.001 mg/ml (e). After a 60-min incubation  at 37~ 
the reaction was stopped by adding EDTA (0.1 mM) and 
catalase (1,000 U/ml), and the concentration of nitrite was 
measured. Data are the means of duplicates. 
ogenous deoxyribonucleosides  can be taken up by cells and 
phosphorylated to deoxyribonudeotides  (37-39). If cytostasis 
by activated macrophages were due mainly to inhibition of 
tumor cell RR, exogenous deoxyribonucleosides might par- 
tially reverse the cytostatic effect by bypassing RR. We there- 
fore added deoxyribonucleosides to tumor cells whose DNA 
synthesis was blocked either by the RR inhibitor hydrox- 
yurea (22), or by NO-generating activated macrophages. A 
wide range  of concentrations  of each  of the  four  deox- 
yribonucleosides was tested, alone and in all possible combi- 
nations (data not shown). The optimal regimen to reverse 
partially the cytostasis caused by hydroxyurea was the addi- 
tion of deoxyadenosine and deoxyguanosine at 0.4 mM each. 
Under these conditions, [3H]thymidine  incorporation was 
restored to 38-63% of that by L1210 cells not receiving hydrox- 
yurea (Fig. 7, inset).  When activated macrophages were used 
in place of hydroxyurea, cytostasis was equally profound, and 
was reversed to a similar degree by deoxyadenosine and deox- 
yguanosine (Fig. 7, main figure).  The deoxyribonucleosides 
did not affect nitrite production by the macrophages  (data 
not shown). 
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Figure 6.  Mass  spectrum of nitrosomorpholine  generated from the oxi- 
dation of hydroxyurea in the presence of morpholine. Oxidation of hydrox- 
yurea (0.3 raM) with 10/~M CuSO4 and 2 mM HzO2 was carried out 
in the presence of 10 mM morpholine to trap generated NO. The reaction 
mixture was extracted with dichloroethane, concentrated under N2, and 
analyzed by GC/MS. A peak eluting at 3.8 min showed a molecular ion 
of m/z  116 and base fragment ion of m/z 56. 
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Figure 7.  Effects  of exogenous deoxyribonucleosides on the cytostatic 
effects of intact, activated macrophages or hydroxyurea. Thioglycollate 
broth-elicited peritoneal macrophages were activated with LPS (0.5/~g/ml) 
and IFN-3, (2.5-50 U/ml, as indicated) for 12 h, and cocultured with L1210 
cells in the presence (O) or absence (O) of 0.4 mM deoxyadenosine and 
0.4 mM deoxyguanosine (main  figure). As a positive control, hydroxyurea 
(0.1-1 mM) was used in place of activated macrophages (inset). Incorpora- 
tion of [3H]thymidine was measured, and expressed as a percent of con- 
trol. The controls were incubated with nonactivated macrophages (main 
figure) or without hydroxyurea (inset) in the presence of the same concen- 
trations of deoxyribonucleosides.  Deoxyribonucleosides  alone caused ,x,50% 
inhibition  of thymidine incorporation. Data are means _+ SD of triplicates. 
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Understanding cell-mediated cytotoxicity requires iden- 
tifying not only the toxins released by effector cells, but also 
the critical molecules with which they interact in tumor cells 
and microbes. Known targets for macrophage-derived NO 
include c/s-aconitase  (11), NADH/succinate oxidoreductase 
(8), and NADH/ubiquinone oxidoreductase (8). Inactivation 
of these enzymes appears to account for inhibition of tumor 
cell respiration by activated macrophages. Suppression of tumor 
cell proliferation can now be ascribed, in part, to inhibition 
of tLIL. 
ILIL was susceptible to inhibition at a very low level of 
NO generation, but inactivation of ILK in vitro was far from 
complete. This probably reflects limitations imposed by the 
assay conditions, which require oxygen and relatively large 
concentrations of exogenous iron and thiols. These reactants 
can deplete NO and restore RIL (40, 41).  The major cata- 
lytic components of ILK are ferric ions coupled through/~-oxo 
bridges, tyrosyl radicals, and reduced thiols (17-20, 22). Each 
is a possible site for NO-mediated inactivation. 
While  this  work was  in progress,  Lepoivre et  al.  (42) 
reported  the partial  sensitivity of RK  in  a  hydroxyurea- 
resistant, RR-overproducing routine adenocarcinoma cell line 
that was stimulated to generate endogenous NO by treat- 
ment with cytokines and LPS.  The present report extends 
those results by using tumor cells that were not selected for 
overexpression of RtL; by comparing the effects of biosyn- 
thetic NO with those of reagent NO and hydroxyurea; by 
studying interactions between macrophages and tumor cells; 
by assessing the degree to which tumor cell cytostasis by in- 
tact macrophages could be ascribed to inhibition of KK; and 
by demonstrating that hydroxyurea can generate an NO-like 
compound. 
Generation of NO by hydroxyurea  was unexpected. Hydro- 
xyurea is thought to inhibit RtL by quenching the active 
site tyrosine radical through a one-electron transfer (22). The 
present study suggests that formation of an NO-like reac- 
tant from hydroxyurea may be involved in actions of the drug 
in those cells that can oxidize it. If so, then this pharmaco- 
logic agent, and perhaps other structurally related chemother- 
apeutics (43, 44), may imitate a component of cell-mediated 
cytotoxicity. 
Exogenous purine deoxyribonucleosides partially protected 
tumor cells against inhibition of DNA synthesis by intact, 
activated macrophages and by hydroxyurea. While far from 
complete, protection was comparable for macrophages and 
hydroxyurea. Incomplete protection may reflect the known 
methodologic limitations of bypassing a block in ILK with 
products that compete with each other for transport (39) and 
phosphorylation (38) and can themselves be cytostatic (37, 
38). Alternatively, both hydroxyurea and macrophage-derived 
NO may have additional targets besides ILIL, whose inacti- 
vation contributes to cytostasis.  This is to be expected for 
NO, which is broadly reactive with redox-sensitive molecules, 
and for hydroxyurea, if it generates NO. 
We have only studied RR from tumor cells. However, it 
is likely that RR in microbes is also susceptible to macrophage- 
derived NO. If so, inhibition of RR may contribute to the 
ability of activated macrophages to inhibit the proliferation 
of bacteria,  fungi,  protozoa,  and helminths (9). 
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